3 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow abacavir hydroxyacetate: new trials by email Literature Review of abacavir hydroxyacetate trials Research Report on abacavir hydroxyacetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis Placebo, 400 mg (200 mg BID), 300 mg (150 mg BID) - Chronic Stable Plaque Psoriasis | Phase 2 | Completed | Innovation Pharmaceuticals, Inc. | 199 | 2016-11-01 | 2018-02-13 |
| Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis Prurisol, Placebo - Plaque Psoriasis | Phase 2 | Completed | Cellceutix Corporation | 115 | 2015-08-01 | 2017-07-19 |
| Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers Prurisol, Ziagen - Psoriasis | Phase 1 | Completed | Cellceutix Corporation | 18 | 2014-03-01 | 2018-10-26 |
Psoriasis (2) · Skin Diseases (1)
Cellceutix Corporation (2) · Innovation Pharmaceuticals, Inc. (1)
United States (3)
Krishna Menon (1)